Literature DB >> 19923487

Genital herpes simplex virus type 1 in women: detection in cervicovaginal specimens from gynecological practices in the United States.

Kristen C Peña1, Martin E Adelson, Eli Mordechai, John A Blaho.   

Abstract

Herpes simplex virus types 1 and 2 (HSV-1 and -2) are significant human pathogens causing clinically indistinguishable facial and genital lesions. Recently, the number of reported genital herpes cases caused by type 1 virus has increased. Identifying the HSV type is of clinical importance to determine proper treatment, as there is no licensed vaccine or cure. We assessed, by PCR, the frequency of HSV-1 and HSV-2 present in more than 60,000 clinical cervicovaginal specimens derived from samples originating from 43 continental U.S. states. Fourteen percent were positive for HSV-1 and/or HSV-2. This likely represents subclinal shedding. It was not a measurement of the prevalence of HSV infection. While the majority were HSV-2, 32% were HSV-1. The distribution of HSV types varied between the states with the largest number of specimens, New Jersey, Florida, and Texas. Specimens from women under the age of 24 had an HSV-1 positivity rate of 47 percent. Importantly, in New Jersey, an observed age effect was the disproportionately high prevalence of genital HSV-1 in young women. This represents the largest analysis of HSV types reported and has important public health implications, particularly for younger women.

Entities:  

Mesh:

Year:  2009        PMID: 19923487      PMCID: PMC2812291          DOI: 10.1128/JCM.01336-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  15 in total

1.  Phenotypic and genotypic methods for the detection of herpes simplex virus serotypes.

Authors:  H N Madhavan; K Priya; R Bagyalakshmi
Journal:  J Virol Methods       Date:  2003-03       Impact factor: 2.014

2.  Increase in rates of herpes simplex virus type 1 as a cause of anogenital herpes in western Sydney, Australia, between 1979 and 2003.

Authors:  L J Haddow; B Dave; A Mindel; K A McPhie; C Chung; C Marks; D E Dwyer
Journal:  Sex Transm Infect       Date:  2006-06       Impact factor: 3.519

3.  Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture.

Authors:  Anna Wald; Meei-Li Huang; David Carrell; Stacy Selke; Lawrence Corey
Journal:  J Infect Dis       Date:  2003-10-31       Impact factor: 5.226

Review 4.  Genital herpes.

Authors:  Rachna Gupta; Terri Warren; Anna Wald
Journal:  Lancet       Date:  2007-12-22       Impact factor: 79.321

5.  Rapid isolation of HSV-1 and HSV-2 from OneSwab cervicovaginal specimens.

Authors:  Kristen C Peña; Martin E Adelson; Eli Mordechai; John A Blaho
Journal:  J Virol Methods       Date:  2009-03-25       Impact factor: 2.014

6.  Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant.

Authors:  Zane A Brown; Anna Wald; R Ashley Morrow; Stacy Selke; Judith Zeh; Lawrence Corey
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

7.  Reconsideration of viral protein immunoblotting for differentiation of human herpes simplex viruses.

Authors:  Robert N Bowles; Jamie C Yedowitz; John A Blaho
Journal:  Diagn Microbiol Infect Dis       Date:  2008-07-17       Impact factor: 2.803

8.  Natural history of genital herpes simplex virus type 1 infection.

Authors:  Rebecca Engelberg; David Carrell; Elizabeth Krantz; Lawrence Corey; Anna Wald
Journal:  Sex Transm Dis       Date:  2003-02       Impact factor: 2.830

Review 9.  Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention.

Authors:  L Corey; K K Holmes
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

Review 10.  Genital herpes simplex virus infections: clinical manifestations, course, and complications.

Authors:  L Corey; H G Adams; Z A Brown; K K Holmes
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

View more
  20 in total

1.  Comparison of the host immune response to herpes simplex virus 1 (HSV-1) and HSV-2 at two different mucosal sites.

Authors:  Min Zheng; Christopher D Conrady; Julie M Ward; Katie M Bryant-Hudson; Daniel J J Carr
Journal:  J Virol       Date:  2012-04-24       Impact factor: 5.103

Review 2.  Herpes Genitalis: Diagnosis, Treatment and Prevention.

Authors:  A Sauerbrei
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-10-18       Impact factor: 2.915

3.  Genomic, phylogenetic, and recombinational characterization of herpes simplex virus 2 strains.

Authors:  Aaron W Kolb; Inna V Larsen; Jacqueline A Cuellar; Curtis R Brandt
Journal:  J Virol       Date:  2015-04-08       Impact factor: 5.103

4.  Synthetic α-Hydroxytropolones Inhibit Replication of Wild-Type and Acyclovir-Resistant Herpes Simplex Viruses.

Authors:  Peter J Ireland; John E Tavis; Michael P D'Erasmo; Danielle R Hirsch; Ryan P Murelli; Mark M Cadiz; Bindi S Patel; Ankit K Gupta; Tiffany C Edwards; Maria Korom; Eileen A Moran; Lynda A Morrison
Journal:  Antimicrob Agents Chemother       Date:  2016-03-25       Impact factor: 5.191

5.  Enhanced expression of IFI16 and RIG-I in human third-trimester placentas following HSV-1 infection.

Authors:  A Jabłońska; M Studzińska; P Suski; J Kalinka; E Paradowska
Journal:  Clin Exp Immunol       Date:  2018-08       Impact factor: 4.330

6.  Mapping Murine Corneal Neovascularization and Weight Loss Virulence Determinants in the Herpes Simplex Virus 1 Genome and the Detection of an Epistatic Interaction between the UL and IRS/US Regions.

Authors:  Kyubin Lee; Aaron W Kolb; Inna Larsen; Mark Craven; Curtis R Brandt
Journal:  J Virol       Date:  2016-08-26       Impact factor: 5.103

7.  Herpes simplex virus type 1 is the leading cause of genital herpes in New Brunswick.

Authors:  Richard Garceau; Danielle Leblanc; Louise Thibault; Gabriel Girouard; Manon Mallet
Journal:  Can J Infect Dis Med Microbiol       Date:  2012       Impact factor: 2.471

8.  HSV-1 strain McKrae is more neuroinvasive than HSV-1 KOS after corneal or vaginal inoculation in mice.

Authors:  Hong Wang; David J Davido; Lynda A Morrison
Journal:  Virus Res       Date:  2013-01-20       Impact factor: 3.303

9.  Association between HSV1 seropositivity and obesity: data from the National Health and Nutritional Examination Survey, 2007-2008.

Authors:  Zuzana Karjala; Diane Neal; James Rohrer
Journal:  PLoS One       Date:  2011-05-11       Impact factor: 3.240

10.  High-purity preparation of HSV-2 vaccine candidate ACAM529 is immunogenic and efficacious in vivo.

Authors:  Sophia T Mundle; Hector Hernandez; John Hamberger; John Catalan; Changhong Zhou; Svetlana Stegalkina; Andrea Tiffany; Harry Kleanthous; Simon Delagrave; Stephen F Anderson
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.